Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B
Molecular Therapy - Methods & Clinical Development · 2023-09 · 30 · 534-545
DOI: 10.1016/j.omtm.2023.08.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy - Methods & Clinical Development, 2023-09. Verfasst von Samantha C Lau und 14 weiteren Autor:innen. Beteiligte Einrichtung: Inner Ear Gene Therapy Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, …. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, National Institutes of Health, National Eye Institute.
Abstract (Originalsprache)
Usher syndrome is the most common cause of deafness-blindness in the world. Usher syndrome type 1B (USH1B) is associated with mutations in MYO7A. Patients with USH1B experience deafness, blindness, and vestibular dysfunction. In this study, we applied adeno-associated virus (AAV)-mediated gene therapy to the shaker-1 (Myo7a4626SB/4626SB) mouse, a model of USH1B. The shaker-1 mouse has a nonsense mutation in Myo7a, is profoundly deaf throughout life, and has significant vestibular dysfunction. Because of the ∼6.7-kb size of the MYO7A cDNA, a dual-AAV approach was used for gene delivery, which involves splitting human MYO7A cDNA into 5' and 3' halves and cloning them into two separate AAV8(Y733F) vectors. When MYO7A cDNA was delivered to shaker-1 inner ears using the dual-AAV approach, cochlear hair cell survival was improved. However, stereocilium organization and auditory function were not improved. In contrast, in the vestibular system, dual-AAV-mediated MYO7A delivery significantly rescued hair cell stereocilium morphology and improved vestibular function, as reflected in a reduction of circling behavior and improved vestibular sensory-evoked potential (VsEP) thresholds. Our data indicate that dual-AAV-mediated MYO7A expression improves vestibular function in shaker-1 mice and supports further development of this approach for the treatment of disabling dizziness from vestibular dysfunction in USH1B patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inner Ear Gene Therapy Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA.
- Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL, USA.
- Laboratory of Molecular Genetics, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA.
- Mouse Auditory Testing Core Facility, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA.
- Powell Gene Therapy Center, Department of Pediatrics, University of Florida, Gainesville, FL, USA.
- Department of Otolaryngology - Head & Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Förderung
- NEI NIH HHS
- National Institutes of Health
- National Eye Institute
- NIDCD
- Doris Duke Charitable Foundation
- American Association for Dental, Oral, and Craniofacial Research
- NHLBI Division of Intramural Research
Zitieren
APA
Lau, S. C., Grati, M., Isgrig, K., Sinan, M., Calabro, K. R., Zhu, J., Ishibashi, Y., Ozgur, Z., Wafa, T., Belyantseva, I. A., Fitzgerald, T., Friedman, T. B., Boye, S. L., Boye, S. E., & Chien, W. W. (2023). Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B. Molecular Therapy - Methods & Clinical Development, 30, 534-545. https://doi.org/10.1016/j.omtm.2023.08.012
Vancouver
Lau SC, Grati M, Isgrig K, Sinan M, Calabro KR, Zhu J, et al. Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B. Molecular Therapy - Methods & Clinical Development. 2023;30:534-545. doi:10.1016/j.omtm.2023.08.012
BibTeX
@article{Lau2023,
author = {Lau, Samantha C and Grati, Mhamed and Isgrig, Kevin and Sinan, Moaz and Calabro, Kaitlyn R and Zhu, Jianliang and Ishibashi, Yasuko and Ozgur, Zeynep and Wafa, Talah and Belyantseva, Inna A and Fitzgerald, Tracy and Friedman, Thomas B and Boye, Sanford L and Boye, Shannon E and Chien, Wade W},
title = {Dual-AAV vector-mediated expression of MYO7A improves vestibular function in a mouse model of Usher syndrome 1B},
journal = {Molecular Therapy - Methods & Clinical Development},
year = {2023},
volume = {30},
pages = {534--545},
doi = {10.1016/j.omtm.2023.08.012}
}
EUVIMED